Strategic Leadership Moves Signal European Expansion for Real Chemistry

In a move designed to amplify its global reach, Real Chemistry, a prominent force in healthcare marketing and communications, has announced key leadership changes focused on strengthening its European operations. These appointments underscore the company’s commitment to addressing the evolving needs of its international clientele and capitalizing on growth opportunities within the European market.

Camilla Griffiths Appointed to Lead 21GRAMS Europe

Camilla Griffiths, a seasoned veteran in healthcare advertising, has been named President of 21GRAMS Europe.with nearly 15 years of experience, Griffiths brings a wealth of knowledge in crafting impactful creative campaigns, fostering team leadership, and managing financial operations. Her previous role as Group Managing director at Havas Lynx Group saw her successfully leading multiple agency teams and spearheading global campaigns for major pharmaceutical brands.

As President, Griffiths will spearhead agency growth, cultivate a collaborative and creative environment, and solidify 21GRAMS’ presence across the UK and broader European markets. Her appointment reflects Real Chemistry’s dedication to innovative and impactful healthcare communications.

21GRAMS is known for its bold, creative-first approach to healthcare communications, which aligns perfectly with my own passion.I’m thrilled to be joining, especially at such a pivotal moment of growth.
Camilla Griffiths, President, 21GRAMS Europe

Mike Nelson Takes on International Client Development Role in London

Further demonstrating its commitment to global expansion, Real Chemistry has relocated Mike Nelson, formerly President, Integrated Communications, to London.In his new role, Nelson will focus on driving international client development, leveraging his extensive experience to meet the increasing global demands of Real Chemistry’s clients.

Nelson, a 13-year veteran of Real Chemistry, is recognized for his strategic acumen and ability to forge strong partnerships. He will serve as a senior client strategist, building teams tailored to client needs and identifying international growth opportunities across both existing and prospective clients. His client portfolio includes leading pharmaceutical companies, biotech firms, medical device manufacturers, diagnostic companies, non-profit organizations, and academic institutions.

Nelson’s prior experience includes leading global communications, advocacy, and policy initiatives for roche in Basel, Switzerland, providing him with a deep understanding of the european healthcare landscape.

I’m excited to take on this new role in London and help shape the next phase of Real Chemistry’s global growth. as the healthcare landscape continues to evolve, we have a tremendous prospect to deliver innovative, data-driven communications strategies that will make a real impact for our clients, while connecting patients with healthcare innovations that will help them lead better and longer lives.
Mike Nelson, President, Integrated Communications, Real chemistry

The Growing Importance of Healthcare Communications in Europe

These strategic moves come at a time when the healthcare communications market in Europe is experiencing significant growth. According to a recent report by Statista, the pharmaceutical market in Europe is projected to reach over $300 billion by 2025, highlighting the increasing demand for effective communication strategies to reach both healthcare professionals and patients. Real Chemistry’s investment in European leadership positions it to capitalize on this growing market.

Real Chemistry: A Global Leader in Healthcare Innovation

Real Chemistry stands as a trusted partner to leading life sciences and healthcare organizations worldwide. Leveraging AI-powered audience analytics and insights, the company helps clients understand, reach, and engage with patients and professionals through innovative and human-centric healthcare experiences. With over 2,000 experts spanning life sciences, marketing communications, and technology, Real chemistry is dedicated to maximizing the potential of modern medical therapies.